GAIN for loss: Adalimumab for infliximab-refractory Crohn disease

Research output: Contribution to journalEditorialpeer-review

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)888-890
Number of pages3
JournalAnnals of internal medicine
Volume146
Issue number12
DOIs
StatePublished - Jun 5 2007

ASJC Scopus subject areas

  • Internal Medicine

Cite this